Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001601485-22-000053
Filing Date
2022-06-13
Accepted
2022-06-13 17:27:20
Documents
1
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165515561728971.html 4  
1 FORM 4 wf-form4_165515561728971.xml 4 3987
  Complete submission text file 0001601485-22-000053.txt   5223
Mailing Address
Business Address
GANZI VICTOR F (Reporting) CIK: 0001199070 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39990 | Film No.: 221012667

Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Issuer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations